Simplex Trading’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-300
| Closed | -$10.2K | – | 9948 |
|
|
2025
Q4 | $10.2K | Hold |
300
| – | – | ﹤0.01% | 6974 |
|
|
2025
Q3 | $7K | Hold |
300
| – | – | ﹤0.01% | 8134 |
|
|
2025
Q2 | $2K | Buy |
+300
| New | +$2.29K | ﹤0.01% | 8193 |
|
|
2024
Q3 | – | Sell |
-525
| Closed | -$12K | – | 9369 |
|
|
2024
Q2 | $12K | Sell |
525
-29,000
| -98% | -$1.34M | ﹤0.01% | 7315 |
|
|
2024
Q1 | $2.12M | Buy |
29,525
+23,237
| +370% | +$3.23M | ﹤0.01% | 2359 |
|
|
2023
Q4 | $1.25M | Buy |
6,288
+6,163
| +4,930% | +$763K | ﹤0.01% | 2808 |
|
|
2023
Q3 | $16K | Buy |
125
+112
| +862% | +$18.3K | ﹤0.01% | 6831 |
|
|
2023
Q2 | $1K | Sell |
13
-1,187
| -99% | -$185K | ﹤0.01% | 8700 |
|
|
2023
Q1 | $176K | Buy |
+1,200
| New | +$243K | ﹤0.01% | 4478 |
|
|
2022
Q3 | – | Sell |
-13
| Closed | -$1K | – | 10707 |
|
|
2022
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 9649 |
|
|
2022
Q1 | $2K | Sell |
13
-312
| -96% | -$58.9K | ﹤0.01% | 9916 |
|
|
2021
Q4 | $95K | Sell |
325
-9,688
| -97% | -$2.59M | ﹤0.01% | 6336 |
|
|
2021
Q3 | $2.46M | Buy |
10,013
+150
| +2% | +$39.7K | ﹤0.01% | 1900 |
|
|
2021
Q2 | $2.51M | Buy |
9,863
+9,857
| +164,283% | +$1.84M | ﹤0.01% | 1881 |
|
|
2021
Q1 | $97K | Buy |
6
+3
| +100% | +$495 | ﹤0.01% | 5791 |
|
|
2020
Q4 | $53K | Buy |
+3
| New | +$652 | ﹤0.01% | 6118 |
|
Simplex Trading's RAPT Position: Q1 2026 in Review
Simplex Trading sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 2,846 shares — an estimated $96.4K sold.
Simplex Trading first reported a position in RAPT in Q4 2020 and held it in 13 quarters. The position peaked at $1.47M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Simplex Trading reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 2,846 RAPT Therapeutics shares in Q1 2026, an estimated $96.4K.
- Simplex Trading first reported a position in RAPT Therapeutics in Q4 2020 and held it in 13 quarters.
- Simplex Trading's RAPT Therapeutics position peaked at $1.47M in Q3 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.